Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes
This study has been completed.
Study NCT00071409   Information provided by Procter and Gamble

First Received on October 22, 2003.   Last Updated on August 4, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
INGAP-Peptide
placebo
Sponsors listed in this trial
Procter and Gamble


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services